Medical device approved to treat epilepsy
The U.S. Food and Drug Administration today approved a device to help reduce the frequency of seizures in epilepsy patients who have not responded well to medications. The RNS Stimulator … continue reading
The U.S. Food and Drug Administration today approved a device to help reduce the frequency of seizures in epilepsy patients who have not responded well to medications. The RNS Stimulator … continue reading
Surgical confusions—for instance, operations involving the wrong site, the wrong patient or the wrong procedure—occur infrequently in eye surgery procedures, according to a report in the November issue of Archives of Ophthalmology, one of the JAMA/Archives journals. Although most surgical confusions cause little or no permanent injury, they may involve serious consequences for the patient, physician and profession, yet could often be prevented.
Prostate cancer patients cut their risk of dying of the disease in half when they receive radiation seed implants (brachytherapy) to treat their cancer, compared to those who don’t receive active treatment (watchful waiting/active surveillance), within six months from being diagnosed with localized prostate cancer, according to a study presented October 31, 2007, at the American Society for Therapeutic Radiology and Oncology’s 49th Annual Meeting in Los Angeles.
Researchers have discovered a strain of bacteria resistant to all approved drugs used to fight ear infections in children, according to an article published today in the Journal of the American Medical Association (JAMA). A pair of pediatricians discovered the strain because it is their standard practice to perform an uncommon procedure called tympanocentesis (ear tap) on children when several antibiotics fail to clear up their ear infections. The procedure involves puncturing the child’s eardrum and draining fluid to relieve pressure and pain. Analyzing the drained fluid is the only way to describe the bacterial strain causing the infection.
Women with breast cancer often seek immediate breast reconstruction after a mastectomy to help them regain a semblance of their body and for their psychological peace of mind. As part of Breast Cancer Awareness Month in October, Thomas Jefferson University Hospital is re-airing its webcast on one of the most often performed breast reconstruction surgical procedures, using muscle tissue from a patient’s back.
FDA informed healthcare professionals and consumers that the Cochlear Implant device used in profoundly deaf or severely hard-of hearing patients has been associated with some increased risk of bacterial meningitis caused by Streptococcus pneumoniae.
A new and extraordinary $22 million gift to the University of Michigan Health System is making possible a new and extraordinary institute — one with a mission of supporting fundamental research to advance the understanding of the causes, treatment and prevention of a broad range of human diseases.
In a period of just 13 days, a 56-year-old Gilbert, Ariz., woman has felt the beating of three different hearts – all within her own chest: First, her own, failing heart. Then, in what is considered groundbreaking in the Valley, an artificial heart. And, on day 13, a donor heart.
For orthopaedic implants to be successful, bone must meld to the metal that these artificial hips, knees and shoulders are made of. A team of Brown University engineers, led by Thomas Webster, has discovered a new material that could significantly increase this success rate.
VeriChip Corporation (NASDAQ: CHIP), a provider of RFID systems for healthcare and patient-related needs, responded in an effort to set the record straight in response to unbalanced press reports relating malignant tumors to the Company’s implantable microchips.